UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
42 hedge funds and large institutions have $8.4M invested in Unity Biotechnology in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7.6% more ownership
Funds ownership: 18.32% → 25.93% (+7.6%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
Holders
42
Holding in Top 10
3
Calls
$2.63M
Puts
$32K
Top Buyers
| 1 | +$1.94M | |
| 2 | +$1.33M | |
| 3 | +$93.9K | |
| 4 |
Morgan Stanley
New York
|
+$82.7K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$40.5K |
Top Sellers
| 1 | -$167K | |
| 2 | -$93.5K | |
| 3 | -$27.4K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$19.1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.22K |